









市场行情
/
股票
/
nasdaq-livn
/

LivaNova PLC

LIVN

62.820USD

+0.740+1.19%

收盘 12/19, 16:00（美东）报价延迟15分钟

3.43B总市值

亏损市盈率 TTM



LivaNova PLC

62.820

+0.740+1.19%

概览公司财务分析

概览

公司

财务

分析

关于 LivaNova PLC 公司

LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.

LivaNova PLC简介



公司代码LIVN

公司名称LivaNova PLC

上市日期Oct 19, 2015

CEOMakatsaria (Vladimir A)

员工数量2900

证券类型Ordinary Share

年结日Oct 19

公司地址20 Eastbourne Terrace

城市LONDON

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United Kingdom

邮编W2 6LG

电话442033250662

网址https://www.livanova.com/

公司代码LIVN

上市日期Oct 19, 2015

CEOMakatsaria (Vladimir A)

LivaNova PLC公司高管



名称

名称/职务

职务

持股

持股变动

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

Franco Poletti ,

President, Cardiopulmonary Business Unit

8.52K

+4.49%

Ms. Brooke Story

Independent Director

6.23K

-3.86%

Mr. Michael Damon Hutchinson

Senior Vice President, Chief Legal Officer, Company Secretary

5.67K

Ahmet Tezel

Senior Vice President, Chief Innovation Officer

1.94K

名称

名称/职务

职务

持股

持股变动

Mr. William A. Kozy

Independent Chairman of the Board

32.57K

+15.05%

Mr. Alex Shvartsburg

Chief Financial Officer

26.68K

Ms. Stephanie Bolton

President, Global Epilepsy

12.75K

Dr. Sharon O'Kane, Ph.D.

Independent Director

11.30K

+19.06%

Mr. Todd C. Schermerhorn

Independent Director

9.06K

+49.63%

Mr. Francesco Bianchi

Independent Director

9.03K

-14.25%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

188.47M

53.46%

Rest of World

97.27M

27.59%

Europe

66.78M

18.94%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

其他

66.08%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.60%

PRIMECAP Management Company

8.14%

Millennium Management LLC

5.44%

Artisan Partners Limited Partnership

4.44%

Wellington Management Company, LLP

4.30%

其他

66.08%

股东类型

持股股东

占比

Investment Advisor

49.17%

Investment Advisor/Hedge Fund

36.44%

Hedge Fund

13.06%

Research Firm

3.19%

Pension Fund

2.29%

Bank and Trust

1.34%

Individual Investor

0.37%

Sovereign Wealth Fund

0.09%

Insurance Company

0.04%

机构持股



更新时间: 10月5日周日

报告期

机构数

持股数

持股占比

持股变动

2025Q3

562

56.86M

104.13%

-8.50M

2025Q2

564

56.85M

104.11%

-6.95M

2025Q1

581

56.61M

103.82%

-8.04M

2024Q4

586

56.98M

104.84%

-8.56M

2024Q3

563

55.15M

101.56%

-9.48M

2024Q2

546

57.21M

105.64%

-8.52M

2024Q1

547

58.00M

107.51%

-6.90M

2023Q4

532

56.62M

105.11%

-7.28M

2023Q3

527

56.14M

104.20%

-8.51M

2023Q2

529

55.56M

103.33%

-9.55M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

6.37M

11.67%

-150.58K

-2.31%

Jun 30, 2025

PRIMECAP Management Company

4.64M

8.5%

+32.94K

+0.71%

Jun 30, 2025

Millennium Management LLC

2.43M

4.44%

+360.76K

+17.47%

Jun 30, 2025

Artisan Partners Limited Partnership

1.25M

2.29%

+661.48K

+112.86%

Jun 30, 2025

Wellington Management Company, LLP

1.28M

2.34%

+805.32K

+170.32%

Jun 30, 2025

The Vanguard Group, Inc.

2.44M

4.47%

-214.69K

-8.09%

Jun 30, 2025

State Street Investment Management (US)

2.08M

3.81%

-17.41K

-0.83%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

1.61M

2.96%

+282.33K

+21.20%

Jun 30, 2025

AQR Capital Management, LLC

2.05M

3.75%

+478.52K

+30.45%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.43M

2.62%

+18.55K

+1.31%

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

1.66%

JPMorgan Active Small Cap Value ETF

1.43%

Invesco NASDAQ Future Gen 200 ETF

0.5%

Simplify Health Care ETF

0.43%

Global X Aging Population ETF

0.42%

JPMorgan Fundamental Data Science Small Core ETF

0.37%

Avantis US Small Cap Equity ETF

0.34%

iShares U.S. Medical Devices ETF

0.34%

WisdomTree US SmallCap Fund

0.33%

Federated Hermes MDT Small Cap Core ETF

0.33%

State Street SPDR S&P Health Care Equipment ETF

占比1.66%

JPMorgan Active Small Cap Value ETF

占比1.43%

Invesco NASDAQ Future Gen 200 ETF

占比0.5%

Simplify Health Care ETF

占比0.43%

Global X Aging Population ETF

占比0.42%

JPMorgan Fundamental Data Science Small Core ETF

占比0.37%

Avantis US Small Cap Equity ETF

占比0.34%

iShares U.S. Medical Devices ETF

占比0.34%

WisdomTree US SmallCap Fund

占比0.33%

Federated Hermes MDT Small Cap Core ETF

占比0.33%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

LivaNova PLC的前五大股东是谁？



LivaNova PLC 的前五大股东如下：
BlackRock Institutional Trust Company, N.A.持有股份：6.37M，占总股份比例：11.67%。
PRIMECAP Management Company持有股份：4.64M，占总股份比例：8.50%。
Millennium Management LLC持有股份：2.43M，占总股份比例：4.44%。
Artisan Partners Limited Partnership持有股份：1.25M，占总股份比例：2.29%。
Wellington Management Company, LLP持有股份：1.28M，占总股份比例：2.34%。